M&A Deal Summary

Par Pharmaceutical Acquires Nuray Chemicals - Manufacturing Facility

On June 17, 2015, Par Pharmaceutical acquired life science company Nuray Chemicals - Manufacturing Facility from Nuray Chemicals Pvt.

Acquisition Highlights
  • This is Par Pharmaceutical’s 2nd transaction in the Life Science sector.
  • This is Par Pharmaceutical’s 2nd transaction in India.

M&A Deal Summary

Date 2015-06-17
Target Nuray Chemicals - Manufacturing Facility
Sector Life Science
Buyer(s) Par Pharmaceutical
Sellers(s) Nuray Chemicals Pvt.
Deal Type Divestiture

Target

Nuray Chemicals - Manufacturing Facility

India
Nuray Chemicals - Manufacturing Facility engages in manufacturing, and distributing of generic drugs

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Par Pharmaceutical

Spring Valley, New York, United States

Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Par Pharmaceutical, Inc. is a developer, manufacturer, and distributor of generic drugs in the United States.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
Country: India M&A 2 of 2
Year: 2015 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-17 Edict Pharmaceuticals Pvt.

Kelambakkam, India

Edict Pharmaceuticals Pvt. Ltd. is a provider of contract research and manufacturing services for the United States and other regulated markets.

Buy -

Seller(S) 1

SELLER

Nuray Chemicals Pvt.

Kakkalur, India

Category Company
Founded 2012
Sector Life Science
DESCRIPTION

Nuray Chemicals Pvt. Ltd. is a developer and manufacturer of active pharmaceutical ingredients.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: India M&A 1 of 1
Year: 2015 M&A 1 of 1